Insights from 2023 ASH Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASH 2023 Insights: "The European MCL Network R2 Elderly Trial - R2 vs. R Maintenance After 1L Chemoimmunotherapy in Elderly MCL Patients"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Vincent Ribrag
By
Insights from 2023 ASH Annual Meeting
FEATURING
Vincent Ribrag
Comments 0
Login to view comments.
Click here to Login
